We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$14.1B
AUM Growth
-$2.26B
Cap. Flow
-$2.67B
Cap. Flow %
-18.96%
Top 10 Hldgs %
31.21%
Holding
649
New
82
Increased
157
Reduced
258
Closed
99

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$270M
2
MSFT icon
Microsoft
MSFT
+$195M
3
UNH icon
UnitedHealth
UNH
+$192M
4
JNJ icon
Johnson & Johnson
JNJ
+$164M
5
AAPL icon
Apple
AAPL
+$135M

Sector Composition

Rank Sector Weight
1 Technology 29.64%
2 Healthcare 19.28%
3 Financials 12.06%
4 Communication Services 9.18%
5 Consumer Discretionary 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSS icon
401
Federal Signal
FSS
$7.19B
$768K 0.01%
+32,994
New +$768K
PRAH
402
DELISTED
PRA Health Sciences, Inc.
PRAH
$766K 0.01%
8,200
CNC icon
403
Centene
CNC
$31.6B
$764K 0.01%
+12,400
New +$715K
PRDO icon
404
Perdoceo Education
PRDO
$2.06B
$758K 0.01%
46,900
+8,400
+22% +$122K
BBD icon
405
Banco Bradesco
BBD
$38.3B
$754K 0.01%
175,580
+151,159
+619% +$820K
SNX icon
406
TD Synnex
SNX
$19.8B
$753K 0.01%
15,600
+3,600
+30% +$192K
LEXEA
407
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$751K 0.01%
17,100
+7,000
+69% +$292K
BIO icon
408
Bio-Rad Laboratories Class A
BIO
$8.86B
$750K 0.01%
2,600
LRN icon
409
Stride
LRN
$4.08B
$750K 0.01%
45,800
+4,900
+12% +$76K
BAK icon
410
Braskem
BAK
$944M
$749K 0.01%
28,800
-16,300
-36% -$421K
TMO icon
411
Thermo Fisher Scientific
TMO
$214B
$746K 0.01%
3,600
HVT icon
412
Haverty Furniture Companies
HVT
$421M
$743K 0.01%
34,400
+2,600
+8% +$51.8K
PAHC icon
413
Phibro Animal Health
PAHC
$1.48B
$737K 0.01%
+16,000
New +$708K
WEB
414
DELISTED
Web.com Group, Inc.
WEB
$734K 0.01%
28,400
BGC icon
415
BGC Group
BGC
$5.73B
$728K 0.01%
99,987
-228,274
-70% -$1.82M
MFC icon
416
Manulife Financial
MFC
$74.2B
$728K 0.01%
40,500
-157,100
-80% -$2.96M
CVG
417
DELISTED
Convergys
CVG
$728K 0.01%
29,800
MCS icon
418
Marcus Corp
MCS
$766M
$725K 0.01%
22,300
+10,500
+89% +$331K
IVZ icon
419
Invesco
IVZ
$13B
$715K 0.01%
26,925
-148,500
-85% -$4.27M
LAUR icon
420
Laureate Education
LAUR
$5.28B
$714K 0.01%
49,800
MYGN icon
421
Myriad Genetics
MYGN
$502M
$714K 0.01%
19,100
QUAD icon
422
Quad
QUAD
$434M
$702K 0.01%
33,700
-600
-2% -$13.1K
UTHR icon
423
United Therapeutics
UTHR
$26.1B
$702K 0.01%
6,200
+200
+3% +$22K
ELP
424
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$701K 0.01%
314,250
KRA
425
DELISTED
Kraton Corporation
KRA
$701K 0.01%
15,200
-3,800
-20% -$185K

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2018 Portfolio in Review

As of Q2 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 649 positions worth $14.1B, down 14% from $16.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.67B in Q2 2018, closing 99 positions and reducing 258 holdings. Its most notable exit was Monsanto Co, an estimated $270M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Shire pic worth $76.5M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2018 buy was Shire pic: 453,200 shares worth $76.5M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Visa in Q2 2018, an estimated $119M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2018 reduction was Microsoft, cutting an estimated $195M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Monsanto Co in Q2 2018, selling an estimated $270M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 31% of its $14.1B portfolio in Q2 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 82 new positions and closed 99 in Q2 2018.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 14% quarter-over-quarter to $14.1B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2018, filed 14 Aug 2018.